drugset / Trial / NCT01682408
Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess Bioavailability
RandomizedOpen-labelBasic science
Summary
Study to Assess the Pharmacokinetics of R406 in Healthy Subjects when Fostamatinib 150 mg is Administered Alone in Fed and Fasted state and in Combination with Ranitidine in Fasted State, and to Assess the Relative Bioavailability of Process Variants of Tablets
Timeline
- Start
- 2012-09
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fostamatinib | Small molecule | 150 mg | — |
| Comparator | Ranitidine | Unknown | 150 mg | — |
Indications
No indication recorded.